| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Monday June 25; 1230 - 1400 |
1 Toronto General Hospital, University Health Network, Toronto, ON, Canada
2 Toronto General Hospital, University Health Network
3 Toronto General Hospital, University Health Network
4 Toronto General Hospital, University Health Network
5 Toronto General Hospital, University Health Network
Abstract
INTRODUCTION: To date, no meta-analyses assessing the efficacy of perioperative betablockade trials has considered the influence of heart rate control. A systematic review of all perioperative beta blockade studies prior to 2005 suggested that there was not enough evidence to support the universal perioperative use of beta-blockers. Since then 6 studies have been published, half of which show benefit (1,2,3) while the other half cannot show such a correlation (4,5,6). The purpose of this study is to update the systematic review with newer trials, published in the last year, and to consider the influence of tight heart rate control and agent half-life on the efficacy of perioperative beta blockade.
METHODS: For the purpose of this analysis the outcome of interest was in hospital myocardial infarction (MI) after non-cardiac surgery in all randomized trials evaluating perioperative beta-blockers. Relative Risk (RR) and 95% confidence intervals (CI) were calculated using REVMAN 4.2 (Cochrane collaboration). Two subgroup analyses were carried out comparing the efficacy of short and long half-life beta-blockers and the degree of heart rate control. The measure of heart rate control was the upper 95% CI for postoperative heart rate (HR) in patients receiving beta-blockers. This index of heart rate control was plotted against RR for MI in each trial.
RESULTS: The results of the updated analysis are seen in figure 1
. Patients receiving short acting beta-blockers were not protected against perioperative MI (RR 1.08; 95% CI 0.74–1.49; P=0.69), whereas longer acting and continuous infusion beta-blockers were (RR 0.20; 95% CI 0.06–0.64; P=0.007). The longer acting agents were associated with less variability in heart rates as compared to the shorter acting agents.
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |